Related Experiment Video

Updated: May 20, 2026

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

EGFR R521K predicts cetuximab response in KRAS wild-type patients

Sharon Marsh1

  • 1Faculty of Pharmacy & Pharmaceutical Sciences, 3142F Katz Group Centre for Pharmacy & Health Research, University of Alberta, Edmonton, AB, T6G 2E1, Canada. smarsh@pharmacy.ualberta.ca

Pharmacogenomics
|July 5, 2012
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

Related Experiment Videos

Last Updated: May 20, 2026

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...

Articles linked to this work by shared authors, journal, and citation graph.

Integrating genomic-based clinical decision support into electronic health records.

Personalized medicine·2018

Taxane pharmacogenetics.

Personalized medicine·2018

Fast and frugal trees: translating population-based pharmacogenomics to medication prioritization.

Personalized medicine·2018

eHealth: past and future perspectives.

Personalized medicine·2018

Validation of microRNA pathway polymorphisms in esophageal adenocarcinoma survival.

Cancer medicine·2017

A Bridging Opportunities Work-frame to develop mobile applications for clinical decision making.

Future science OA·2016

Co-designing a study on perspectives toward pharmacogenomic testing in mental health care among youth and caregivers.

Pharmacogenomics·2026

The pharmacogenetic of cyclosporine in Tunisian renal transplantation.

Pharmacogenomics·2026

Current knowledge in pharmacogenomics and precision medicine: perspectives of the PGRN global PGx committee on improving drug therapies in underrepresented ethnic populations.

Pharmacogenomics·2026

U.S. student pharmacists perspectives on the pharmacogenomics of escitalopram and aripiprazole.

Pharmacogenomics·2026

Association of ACE I/D polymorphism with blood pressure response to valsartan-hydrochlorothiazide combination therapy in hypertensive patients from Khyber Pakhtunkhwa, Pakistan.

Pharmacogenomics·2026

Impact of NAT2 acetylation phenotype on toxicity in tuberculosis therapy: a systematic review and meta-analysis.

Pharmacogenomics·2026

Activated coal gangue supplementary cementitious materials: mineral phase evolution, mechanical response, and microstructural strengthening mechanisms in low-carbon blended cement systems.

RSC advances·2026

Measurement of Subcellular Metabolite Concentrations in Relation to Phloem Loading.

Methods in molecular biology (Clifton, N.J.)·2026

Detecting Rapid Changes in Carbon Transport and Partitioning with Carbon-11 (11C).

Methods in molecular biology (Clifton, N.J.)·2026

Short-life bamboo lignocellulose is superior-convertible for advanced bioethanol and nanomaterials to decline CO2 emission and environmental impacts.

International journal of biological macromolecules·2026

Preparation of sludge-based activated carbon and its adsorption performance for Cr(VI) in wastewater.

Journal of the Air & Waste Management Association (1995)·2026

The carbohydrate utilization regulator Cbr1 coordinates nutrient-specific gene activation with selective carbon catabolite repression in a basidiomycete yeast.

PLoS biology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us